Testimony in defense of the FDA, which has come under attack recently for its handling of drug safety.

Bowman considers new polls on the FDA, jury duty, consumer confidence, and Michael Moore.

Patients claiming they were harmed byMerck's drugare likely to prove that the company tried to sit on hard medical evidence with hopes that it could run out the clock on its drugs' patent.

New research findings and a thorough reassessment of older research indicate that drugs like Vioxx can have many important benefits and great potential for addressing serious problems.

How severe is the crisis in the pharmaceutical industry?

How the Food and Drug Administration responds to criticism of its drug safety process will determine whether drug safety actually improves.

With the fates of the Food and Drug Administration and the pharmaceutical industry more intertwined than ever, our health depends on regulatory innovation as much as on scientific progress.